News & Events

Putnam Celebrates International Women’s Day

March 07, 2018
|
Firm News

Diversity of all types is critical to Putnam Associates’ success. Today, on International Women’s Day, we thank all the great women at Putnam who have made significant impacts on our firm. In particular, we’d like to highlight 3 of our outstanding Managers: Whitney Amyot, Kristen Moffat, and Archana Murali.

Drawing from diverse backgrounds, Whitney, Kristen, and Archana are impressive strategists and leaders who have guided many project teams and firm initiatives successfully. Their leadership leverages scientific training, strategic intuition, and passion for Putnam’s project work and consistently yields meaningful insights for our firm and our clients. Thank you Whitney, Kristen, and Archana!

In addition to recognizing the women who contribute to Putnam’s success, the firm would also like to acknowledge organizations in the Boston area which support women’s causes. Putnam has made a donation to Rosie’s Place, a women’s shelter in Boston whose mission is to provide a safe and nurturing environment that helps poor and homeless women find security in their lives.

To learn more about our fantastic managers, please see their bios below.

 Whitney Amyot, Ph.D.    

Whitney has served clients across a broad range of therapeutic areas and strategic issues, with recent engagements including launch planning, access strategies, segmentation and opportunity analysis.  Prior to joining Putnam Associates, Whitney served as part of the start-up team of a boutique life sciences strategy consulting firm where she primarily supported pharmaceutical and biotechnology companies in clinical and pipeline development strategy.  In addition, Whitney carried out the due diligence on both pharmaceuticals and diagnostic/medical devices for life science investor clients. She has more than 10 years experience in scientific research, including positions at the Atlanta Veterans Affairs Hospital Infectious Diseases Department and Emory University School of Medicine’s Pharmacology Department. Whitney earned her Ph.D. in Molecular Microbiology from the Tufts University Graduate School of Biomedical Sciences with a dissertation on bacterial secretion systems in Legionella pneumophila, the causative agent of Legionnaires Disease. She graduated magna cum laude from Emory University with a B.S. in Biology.

Kristen Moffat, Ph.D.    

Kristen has served pharmaceutical and biotechnology clients across a range of specialty therapeutic areas including neurology, dermatology, immunology, and oncology and has worked on engagements focused on franchise strategy development, product forecasting, and strategic brand planning.  Prior to joining Putnam, Kristen worked in the medical technology industry where she specialized in market development strategies for stem cell-based technologies.  Kristen has also previously served as a consultant to biomedical-focused venture capital, business development, and investment firms.

Kristen earned her Ph.D. and M.S. in Biomedical Engineering from Columbia University, B.S. in Materials Engineering and Biomedical Engineering from Carnegie Mellon University, and completed post-doctoral training at Duke University. Throughout her academic career, Kristen’s research has focused on biomaterials and biomechanics, tissue engineering, and cell-material interactions.  While at Columbia, Kristen received a National Science Foundation Pre-Doctoral Fellowship, earned dissertation distinction, and was awarded several national honors for her research. Kristen has authored several peer-reviewed publications and book chapters and has three patents.

Archana Murali, Ph.D.  

Archana has served several major global pharmaceutical and biotechnology clients, with a particular focus on oncology, diagnostics and CNS disorders. Archana has supported several clients on opportunity assessments and prioritization with a strong clinical and scientific focus in addition to commercialization strategies. She has also assisted clients by providing qualitative and quantitative market assessments including physician segmentation, forecasting opportunity for pipeline therapies, competitive strategies and product commercialization strategies. Archana enjoys her role as a mentor within Putnam and working collaboratively with her teams.

Prior to Putnam, Archana earned a Ph.D. in Biological Sciences from Dartmouth College where she developed an animal model of neurodegenerative disease and discovered novel molecular mechanisms that can reverse neurodegenerative changes. She also holds a Masters in Molecular Biology and Bachelor’s degree in Biochemistry both from the University of Madras, India

Strategy for the Life Sciences